tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 262 are a BUY (84.79%), 38 are a HOLD (12.3%), 9 are a SELL (2.91%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 52.8% that have a potential upside of 31.9% achieved within 192 days.
Mark Massaro’s has documented 601 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NTRA, Natera at 22-Oct-2025.
Analyst best performing recommendations are on TKNO (ALPHA TEKNOVA).
The best stock recommendation documented was for GHDX (GENOMIC HEALTH) at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$19
$1.78 (10.34%)
$9
6 days ago
(21-Oct-2025)
5/9 (55.56%)
$2.55 (15.50%)
108
Buy
$20
$2.78 (16.14%)
$15
13 days ago
(14-Oct-2025)
14/15 (93.33%)
$2.89 (16.89%)
321
Hold
$9
$-8.22 (-47.74%)
$10
5 months 23 days ago
(04-May-2025)
6/7 (85.71%)
$-1.03 (-10.27%)
558
Buy
$10
$-7.22 (-41.93%)
$9
5 months 26 days ago
(01-May-2025)
5/6 (83.33%)
$0.16 (1.63%)
96
Buy
$12
$-5.22 (-30.31%)
$15
8 months 15 days ago
(12-Feb-2025)
2/2 (100%)
$3.48 (40.85%)
570
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?
